Ketamine Integration in Emergency Care: Evidence from 2026 Review

Ketamine’s Expanding Role in Emergency Medical Settings

A 2026 peer-reviewed review published in PubMed (PMID: 42893496) evaluates the integrated use of ketamine in emergency care, providing evidence that could influence clinical practice and hospital policy. The study synthesizes recent clinical data on ketamine’s applications for acute pain, sedation, and rapid intervention scenarios, highlighting its unique pharmacological profile and versatility compared to traditional agents.

Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is distinguished by its rapid onset, dissociative anesthesia, and relative preservation of airway reflexes. These properties make it a candidate for acute interventions where speed, safety, and patient stability are critical. The review notes increased adoption of ketamine in pre-hospital care, emergency departments, and trauma settings, especially for patients with contraindications to opioids or benzodiazepines.

Mechanisms and Clinical Context: Why Ketamine?

Ketamine’s mechanism of action involves blocking NMDA receptors, leading to analgesia, sedation, and dissociation without significant respiratory depression. This sets it apart from opioids and other sedatives, which carry higher risks of respiratory compromise. The review details ketamine’s use in acute pain management, procedural sedation, and as an adjunct in rapid sequence intubation (RSI).

Recent clinical trials and observational studies cited in the review demonstrate ketamine’s efficacy for pain control in trauma, burn, and orthopedic emergencies, as well as its utility in agitated or combative patients where rapid sedation is necessary. Notably, the review includes data from multicenter studies in North America and Europe, indicating a trend toward standardized protocols for ketamine administration in emergency settings.

Policy and Research Implications for Emergency Medicine

The evidence presented in this 2026 review has direct implications for clinical protocols, hospital policy, and emergency medicine training. As ketamine’s safety profile becomes better established, hospital systems may revise guidelines to include ketamine as a first- or second-line agent for specific indications, such as severe pain unresponsive to opioids or procedural sedation in high-risk patients.

• Protocol Development: The review’s findings may inform the creation of standardized dosing and monitoring protocols, reducing variability in practice and improving patient outcomes.
• Training and Education: Emergency medicine residency programs and continuing education courses may expand their curricula to include ketamine pharmacology, administration, and adverse event management.
• Policy and Reimbursement: While not a regulatory decision, the accumulation of peer-reviewed evidence can influence payer decisions and hospital formularies, potentially increasing access to ketamine for appropriate cases.

An underappreciated implication is the potential for ketamine protocols to reduce reliance on opioids in emergency care, which may have downstream effects on opioid stewardship and public health.

Risks, Unknowns, and Safety Considerations

Despite its advantages, ketamine use in emergency care is not without risks. The review highlights concerns about emergence reactions (such as hallucinations or agitation), cardiovascular stimulation (tachycardia, hypertension), and rare but serious adverse events like laryngospasm. The evidence base for long-term outcomes and rare side effects remains limited, particularly in pediatric and geriatric populations.

Another challenge is the potential for off-label or inappropriate use, as ketamine’s dissociative effects may be misapplied outside of evidence-based indications. The review calls for robust monitoring, clear protocols, and ongoing provider education to mitigate these risks. Notably, the study points to real-world examples where lack of standardized training led to dosing errors or delayed recognition of adverse events, underscoring the importance of implementation science in translating evidence to practice.

Looking Forward: Research and Policy Directions

Future research will need to address gaps in long-term safety, optimal dosing strategies for diverse populations, and comparative effectiveness versus other agents. The 2026 review recommends multicenter randomized controlled trials (RCTs) and post-marketing surveillance to further define ketamine’s risk-benefit profile in emergency contexts.

For policymakers and hospital administrators, the evolving evidence base may prompt updates to formularies, credentialing requirements, and quality assurance measures. As ketamine’s role in emergency care expands, interdisciplinary collaboration between emergency physicians, pharmacists, and policy experts will be critical to ensure safe, equitable, and evidence-based integration.

How we research: This article was written by Dr. Alex M. Hart, MD, MPH, emergency medicine physician and clinical researcher. Reviewed by Dr. Hart on 2026-10-19. Primary source: PubMed PMID: 42893496.